Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Opioid Use Disorder
NCT06943859Phase 2Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2026
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ketamine in opioid use disorder (OUD) (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Tonic craving total scores. Started Feb 2026; status: recruiting.
02
Drugs
ketamine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06943859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06943859.